A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers
NCT04710290 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2021-01-25
Summary
Immunity of cancer patients is an important issue. According to cancer immunity, it can be divided into three phases: clearance phase, equilibrium phase, and escape phase (cancer cells can avoid the recognition of immune cells). Βeta-glucans is extracted from yeast, it can increase immune function and drive of hematopoietic stem cells in animals and clinical trials. Glutamine can increase the repair of oral and intestinal mucosa of patients receiving chemical and radiation therapy and can increase the lymphocytes of patients. Colostrum contains IgA, IgG, IgM, etc., known to protect the baby Cancer patients who are infected with intestinal bacteria and undergo systemic chemotherapy are less immune than normal adults.
Investigators will compare β-glucan, glutamine, and colostrum immunoglobulin powder with β-glucan and control group, each group has 30 people, and observe the side effects and blood of patients under standard chemotherapy. The performance of the immune system, such as helpers and cytotoxic T cells and NK cells, and to observe the differences in treatment interruption or delay rates and treatment rates.
Conditions
- Metastatic Cancer
- Chemotherapy
Interventions
- DIETARY_SUPPLEMENT
-
Beta-Glucan
Solid beverage powders, capsules and placebo were randomly assigned. The main components of the solid beverage powder are beta-glucan combined with glutamine and immunoglobuin.and the main component of the capsule is beta-glucan . The main ingredient of placebo is corn starch.
- DIETARY_SUPPLEMENT
-
Glutamine
Solid beverage powders, capsules and placebo were randomly assigned. The main components of the solid beverage powder are beta-glucan combined with glutamine and immunoglobuin.and the main component of the capsule is beta-glucan . The main ingredient of placebo is corn starch.
- DIETARY_SUPPLEMENT
-
Immunoglobuin
Solid beverage powders, capsules and placebo were randomly assigned. The main components of the solid beverage powder are beta-glucan combined with glutamine and immunoglobuin.and the main component of the capsule is beta-glucan . The main ingredient of placebo is corn starch.
- DIETARY_SUPPLEMENT
-
Corn starch
Solid beverage powders, capsules and placebo were randomly assigned. The main components of the solid beverage powder are beta-glucan combined with glutamine and immunoglobuin.and the main component of the capsule is beta-glucan . The main ingredient of placebo is corn starch.
Sponsors & Collaborators
-
E-DA Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-04
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy
NCT01760616 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical Study of MAK Immune Cells in the Treatment of PHC
NCT05242757 ·Status: UNKNOWN ·Phase: NA
-
Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells
NCT00562666 ·Status: TERMINATED ·Phase: PHASE1
-
The Effects of Vitamin B-6 and Coenzyme Q10 Status on Oxidative Stress, Antioxidant Capacities, and Inflammatory Responses in Patients With Liver Cancer
NCT01964001 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Synergistic Immunomodulatory Effect of Synbiotics Pre and Postoperative Resection of Pancreatic Ductal Adenocarcinoma
NCT06199752 ·Status: COMPLETED ·Phase: PHASE4
-
Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)
NCT01448668 ·Status: UNKNOWN
-
Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer
NCT00137761 ·Status: COMPLETED ·Phase: PHASE2
-
The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
NCT06368063 ·Status: RECRUITING ·Phase: PHASE4
-
Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial]
NCT01879878 ·Status: UNKNOWN ·Phase: NA
-
Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma
NCT00149565 ·Status: COMPLETED ·Phase: PHASE3
-
Iscar for Supplemental Care in Stage IV Lung Cancer
NCT00079794 ·Status: COMPLETED ·Phase: PHASE2
-
Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer
NCT00283478 ·Status: COMPLETED ·Phase: NA
-
Isolation and Characterization of Cancer Stem Cells Using iFP Technique
NCT01641003 ·Status: UNKNOWN
-
Huaier Granule in Treating Women With Triple Negative Breast Cancer
NCT02615457 ·Status: RECRUITING ·Phase: PHASE4
-
Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC
NCT06900478 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors
NCT07337460 ·Status: RECRUITING ·Phase: PHASE2
-
Iscador Qu as Supportive Treatment in Colorectal Cancer (Union International Cancer Control, UICC Stages II-IV)
NCT01448655 ·Status: UNKNOWN
-
Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer
NCT03984214 ·Status: COMPLETED ·Phase: PHASE3
-
Paullinia Cupana for Anorexia in Oncologic Patients
NCT01540019 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic Cancer
NCT02948309 ·Status: COMPLETED ·Phase: PHASE3
-
Single-Arm Clinical Study of Icaritin Soft Capsules as Adjuvant Therapy for Hepatocellular Carcinoma Patients at High Risk of Postoperative Recurrence
NCT07328828 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
EGCG for Hepatocellular Carcinoma Chemoprevention
NCT06015022 ·Status: RECRUITING ·Phase: PHASE2
-
Recurrence in Buccinator Muscle Excision With the Skin Versus Without the Skin in Buccal Squamous Cell Carcinoma
NCT03364166 ·Status: UNKNOWN ·Phase: NA
-
A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients
NCT06518434 ·Status: RECRUITING ·Phase: PHASE2
-
Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma
NCT06464380 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4